{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:50:11Z","timestamp":1790949011140,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02861-z","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:57:21Z","timestamp":1775800641000},"page":"2097-2112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of patients with hypoparathyroidism: a Delphi consensus analysis"],"prefix":"10.1007","volume":"49","author":[{"given":"Luisella","family":"Cianferotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-1957","authenticated-orcid":false,"given":"Roberto","family":"Ravasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Dinoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Torriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Vescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"6","key":"2861_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.beem.2018.07.001","volume":"32","author":"L Cianferotti","year":"2018","unstructured":"Cianferotti L, Marcucci G, Brandi ML (2018) Causes and pathophysiology of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 32(6):909\u2013925","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"2861_CR2","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/jbmr.4691","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL et al (2022) Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop. J Bone Miner Res. 37(12):2568-2585","journal-title":"J Bone Miner Res"},{"key":"2861_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02760-9","author":"F Cetani","year":"2025","unstructured":"Cetani F, Bertoldo F, Bononi M et al (2025) Unveiling the complexities of hypoparathyroidism: a comprehensive review of clinical manifestations, diagnosis, and novel therapies. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02760-9","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2861_CR4","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV et al (2016) Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab 101(6):2273\u20132283","journal-title":"J Clin Endocrinol Metab"},{"key":"2861_CR5","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L et al (2017) Hypoparathyroidism Nat Rev Dis Primers 3:17055","journal-title":"Hypoparathyroidism Nat Rev Dis Primers"},{"issue":"6","key":"2861_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA et al (2016) Presentation of Hypoparathyroidism: Etiologies and Clinical Features. J Clin Endocrinol Metab 101(6):2300\u20132312","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2861_CR7","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/jbmr.4675","volume":"37","author":"S Bjornsdottir","year":"2022","unstructured":"Bjornsdottir S, Ing S, Mitchell DM, Sikjaer T, Underbjerg L, Hassan-Smith Z et al (2022) Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism. J Bone Min Res 37(12):2602\u20132614","journal-title":"J Bone Min Res"},{"issue":"2","key":"2861_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00223-018-0405-5","volume":"103","author":"L Cianferotti","year":"2018","unstructured":"Cianferotti L, Parri S, Gronchi G et al (2018) Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database. Calcif Tissue Int 103(2):144\u2013150","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"2861_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bjs.9384","volume":"101","author":"O Edafe","year":"2014","unstructured":"Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP (2014) Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg 101(4):307\u2013320","journal-title":"Br J Surg"},{"issue":"6","key":"2861_CR10","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, J\u00fcppner H, Lakatos P, Levine MA et al (2016) Epidemiology and Diagnosis of Hypoparathyroidism. J Clin Endocrinol Metab 101(6):2284\u20132299","journal-title":"J Clin Endocrinol Metab"},{"key":"2861_CR11","doi-asserted-by":"publisher","unstructured":"Topini TCM, Stagni P, Dobreva M et al (2026) Epidemiology of chronic hypoparathyroidism in Italy: a systematic review and meta-analysis. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-026-02827-1","DOI":"10.1007\/s40618-026-02827-1"},{"issue":"5","key":"2861_CR12","first-page":"G49","volume":"193","author":"O Jens Bollerslev","year":"2025","unstructured":"Jens Bollerslev O, Buch M, Cardoso et al (2025) Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults. Eur J Endocrinol 193(5):G49\u2013G78","journal-title":"Eur J Endocrinol"},{"key":"2861_CR13","unstructured":"SANIT\u00c0 ISD Gestione terapeutica dell\u2019ipoparatiroidismo post-chirurgico nell\u2019adulto (2025). https:\/\/www.societaitalianadiendocrinologia.it\/wp-content\/uploads\/2025\/11\/250511_Linee-guida-intersocietarie-ipoparatiroidismo.pdf"},{"issue":"9","key":"2861_CR14","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-2552","volume":"93","author":"KK Winer","year":"2008","unstructured":"Winer KK, Sinaii N, Peterson D, Sainz B Jr., Cutler GB (2008) Jr. Effects of once versus twice-daily parathyroid hormone 1\u201334 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93(9):3389\u20133395","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2861_CR15","first-page":"3480","volume":"83","author":"KK Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB (1998) Jr. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83(10):3480\u20133486","journal-title":"J Clin Endocrinol Metab"},{"key":"2861_CR16","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","volume":"2","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F (2016) Primary hyperparathyroidism. Nat Rev Dis Primers 2:16033","journal-title":"Nat Rev Dis Primers"},{"key":"2861_CR17","unstructured":"EMA EPAR YORVIPATH (palopegteriparatide) (2023). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/yorvipath"},{"issue":"12","key":"2861_CR18","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB et al (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97(12):4507\u20134514","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2861_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12020-020-02577-x","volume":"72","author":"G Marcucci","year":"2021","unstructured":"Marcucci G, Masi L, Cianferotti L, Giusti F, Fossi C, Parri S et al (2021) Chronic hypoparathyroidism and treatment with teriparatide. Endocrine 72(1):249\u2013259","journal-title":"Endocrine"},{"issue":"1","key":"2861_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11136-020-02607-1","volume":"30","author":"M Brod","year":"2021","unstructured":"Brod M, Waldman LT, Smith A, Karpf D (2021) Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact). Qual Life Res 30(1):277\u2013291","journal-title":"Qual Life Res"},{"key":"2861_CR21","doi-asserted-by":"crossref","unstructured":"Kontogeorgos G, Mamasoula Z, Krantz E, Trimpou P, Landin-Wilhelmsen K, Laine CM (2022) Low health-related quality of life in hypoparathyroidism and need for PTH analog. Endocr Connect 11(11):e210379","DOI":"10.1530\/EC-21-0379"},{"issue":"9","key":"2861_CR22","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s40618-022-01800-y","volume":"45","author":"G Marcucci","year":"2022","unstructured":"Marcucci G, Beccuti G, Carosi G et al (2022) Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1\u201384) treatment. J Endocrinol Invest 45(9):1653\u20131662","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2861_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","volume":"38","author":"AA Khan","year":"2023","unstructured":"Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C et al (2023) Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. J Bone Min Res 38(1):14\u201325","journal-title":"J Bone Min Res"},{"issue":"4","key":"2861_CR24","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1210\/clinem\/dgae693","volume":"110","author":"L Bart","year":"2025","unstructured":"Bart L, Clarke AA, Khan, Mishaela R, Rubin et al (2025) Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. J Clin Endocrinol Metab 110(4):951\u2013960","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2861_CR25","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","volume":"41","author":"O Lars Rejnmark, Elvira","year":"2024","unstructured":"Lars Rejnmark, Elvira O, Gosmanova AA, Khan et al (2024) Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial. Adv Ther 41(6):2500\u20132518","journal-title":"Adv Ther"},{"key":"2861_CR26","first-page":"4288","volume-title":"Handbook of Disease Burdens and Quality of Life Measures","year":"2010","unstructured":"Preedy VR, Preedy VR, Watson RR (eds) (2010) Handbook of Disease Burdens and Quality of Life Measures. Springer New York, New York, NY, p 4288"},{"issue":"10","key":"2861_CR27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/ACM.0000000000001812","volume":"92","author":"S Humphrey-Murto","year":"2017","unstructured":"Humphrey-Murto S, Varpio L, Wood TJ, Gonsalves C, Ufholz LA, Mascioli K et al (2017) The Use of the Delphi and Other Consensus Group Methods in Medical Education Research: A Review. Acad Med 92(10):1491\u20131498","journal-title":"Acad Med"},{"key":"2861_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.21315\/eimj2017.9.3.10","volume":"9","author":"R Ab Latif","year":"2017","unstructured":"Ab Latif R, Dahlan A, Abdul Mulud Z, Nor M (2017) The Delphi Technique as a Method to Obtain Consensus in Health Care Education Research. Educ Med J 9:89\u2013102","journal-title":"Educ Med J"},{"key":"2861_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jclinepi.2019.03.011","volume":"111","author":"D De Meyer","year":"2019","unstructured":"De Meyer D, Kottner J, Beele H, Schmitt J, Lange T, Van Hecke A et al (2019) Delphi procedure in core outcome set development: rating scale and consensus criteria determined outcome selection. J Clin Epidemiol 111:23\u201331","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2861_CR30","doi-asserted-by":"publisher","first-page":"e011780","DOI":"10.1136\/bmjopen-2016-011780","volume":"6","author":"P Schneider","year":"2016","unstructured":"Schneider P, Evaniew N, Rendon JS, McKay P, Randall RL, Turcotte R et al (2016) Moving forward through consensus: protocol for a modified Delphi approach to determine the top research priorities in the field of orthopaedic oncology. BMJ Open 6(5):e011780","journal-title":"BMJ Open"},{"issue":"12","key":"2861_CR31","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1038\/s41366-018-0313-9","volume":"43","author":"C Vogel","year":"2019","unstructured":"Vogel C, Zwolinsky S, Griffiths C, Hobbs M, Henderson E, Wilkins E (2019) A Delphi study to build consensus on the definition and use of big data in obesity research. Int J Obes (Lond) 43(12):2573\u20132586","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2861_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41574-024-01075-8","volume":"21","author":"S Khan","year":"2025","unstructured":"Khan S, Khan AA (2025) Hypoparathyroidism: diagnosis, management and emerging therapies. Nat Rev Endocrinol 21(6):360\u2013374","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2861_CR33","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","volume":"105","author":"JP Bilezikian","year":"2020","unstructured":"Bilezikian JP, Hypoparathyroidism (2020) J Clin Endocrinol Metab 105(6):1722\u20131736","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2861_CR34","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/jbmr.4714","volume":"37","author":"JL Pasieka","year":"2022","unstructured":"Pasieka JL, Wentworth K, Yeo CT, Cremers S, Dempster D, Fukumoto S et al (2022) Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. J Bone Min Res 37(12):2586\u20132601","journal-title":"J Bone Min Res"},{"key":"2861_CR35","doi-asserted-by":"crossref","unstructured":"Sitges-Serra A (2021) Etiology and Diagnosis of Permanent Hypoparathyroidism after Total Thyroidectomy. J Clin Med 10(3):543","DOI":"10.3390\/jcm10030543"},{"issue":"4","key":"2861_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ecl.2018.07.006","volume":"47","author":"N Siraj","year":"2018","unstructured":"Siraj N, Hakami Y, Khan A (2018) Medical Hypoparathyroidism. Endocrinol Metab Clin North Am 47(4):797\u2013808","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"2861_CR37","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/jbmr.4667","volume":"37","author":"M Mannstadt","year":"2022","unstructured":"Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA et al (2022) Hypoparathyroidism: Genetics and Diagnosis. J Bone Min Res 37(12):2615\u20132629","journal-title":"J Bone Min Res"},{"issue":"12","key":"2861_CR38","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/jbmr.3854","volume":"34","author":"Y Wang","year":"2019","unstructured":"Wang Y, Nie M, Wang O, Li Y, Jiang Y, Li M et al (2019) Genetic Screening in a Large Chinese Cohort of Childhood Onset Hypoparathyroidism by Next-Generation Sequencing Combined with TBX1-MLPA. J Bone Min Res 34(12):2254\u20132263","journal-title":"J Bone Min Res"},{"issue":"12","key":"2861_CR39","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/jbmr.4716","volume":"37","author":"AA Khan","year":"2022","unstructured":"Khan AA, Guyatt G, Ali DS, Bilezikian JP, Collins MT, Dandurand K et al (2022) Management of Hypoparathyroidism. J Bone Min Res 37(12):2663\u20132677","journal-title":"J Bone Min Res"},{"issue":"12","key":"2861_CR40","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/jbmr.4673","volume":"37","author":"L Yao","year":"2022","unstructured":"Yao L, Hui X, Li M, Li J, Ahmed MM, Lin C et al (2022) Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review. J Bone Min Res 37(12):2642\u20132653","journal-title":"J Bone Min Res"},{"issue":"10","key":"2861_CR41","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/ccr3.2397","volume":"7","author":"J de Oliveira Martins Duarte","year":"2019","unstructured":"de Oliveira Martins Duarte J, Pestana Pereira PML, Sobral ASG, Campoamor Dur\u00e1n D, da Silva Fernandes AI, Rita HJB et al (2019) A rare and reversible case of heart failure-Hypocalcemia due to hypoparathyroidism. Clin Case Rep 7(10):1932\u20131934","journal-title":"Clin Case Rep"},{"issue":"2","key":"2861_CR42","first-page":"191","volume":"147","author":"JKK Tang","year":"2022","unstructured":"Tang JKK, Rabkin SW, Hypocalcemia-Induced QT (2022) Interval Prolongation Cardiol 147(2):191\u2013195","journal-title":"Interval Prolongation Cardiol"},{"issue":"5","key":"2861_CR43","doi-asserted-by":"publisher","first-page":"e2215","DOI":"10.1210\/clinem\/dgab038","volume":"106","author":"G Puliani","year":"2021","unstructured":"Puliani G, Hasenmajer V, Sciarra F, Barbagallo F, Sbardella E, Pofi R et al (2021) Impaired Immune Function in Patients With Chronic Postsurgical Hypoparathyroidism: Results of the EMPATHY Study. J Clin Endocrinol Metab 106(5):e2215\u2013e27","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2861_CR44","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr. et al (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Min Res 23(12):2018\u20132024","journal-title":"J Bone Min Res"},{"issue":"1","key":"2861_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jbmr.4452","volume":"37","author":"KL Roszko","year":"2022","unstructured":"Roszko KL, Hu TY, Guthrie LC, Brillante BA, Smith M, Collins MT et al (2022) PTH 1\u201334 Replacement Therapy Has Minimal Effect on Quality of Life in Patients With Hypoparathyroidism. J Bone Min Res 37(1):68\u201377","journal-title":"J Bone Min Res"},{"issue":"8","key":"2861_CR46","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s40618-023-02271-5","volume":"47","author":"C Cipriani","year":"2024","unstructured":"Cipriani C, Pepe J, Colangelo L et al (2024) Presentation of hypoparathyroidism in Italy: a nationwide register-based study. J Endocrinol Invest 47(8):2021\u20132027. https:\/\/doi.org\/10.1007\/s40618-023-02271-5. (Epub 2024 Jan 4)","journal-title":"J Endocrinol Invest"},{"key":"2861_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2288-5-37","volume":"5","author":"RB Akins","year":"2005","unstructured":"Akins RB, Tolson H, Cole BR (2005) Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 5:37","journal-title":"BMC Med Res Methodol"},{"key":"2861_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.28945\/3561","volume":"11","author":"J Avella","year":"2016","unstructured":"Avella J (2016) Delphi Panels: Research Design, Procedures, Advantages, and Challenges. Int J Doctoral Stud 11:305\u2013321","journal-title":"Int J Doctoral Stud"},{"key":"2861_CR49","first-page":"598","volume":"22","author":"S Iqbal","year":"2009","unstructured":"Iqbal S, Pipon-Young L (2009) The Delphi method. Psychologist 22:598\u2013601","journal-title":"Psychologist"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02861-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02861-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:08:50Z","timestamp":1787292530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02861-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02861-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LC has participated in advisory boards for Ascendis Pharma and UCB Pharma. GM has participated in advisory boards for Ascendis Pharma and BridgeBio. FV has participated in advisory boards for Ascendis Pharma, Theramex and Italfarmco. IC, AD, RR, AT declared no conflict of interest related to the manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}